European Commission buys 160 million doses of Moderna’s Covid-19 vaccine
Share article:
Share article:

European Commission buys 160 million doses of Moderna’s Covid-19 vaccine

Credit: Belga

On Wednesday, the European Commission will approve a contract to buy up to 160 million doses of a Covid-19 vaccine produced by Moderna, President Ursula von der Leyen announced on Tuesday.

According to the results of the clinical trials, the Moderna vaccine could be almost 95% effective against Covid-19.

All vaccines will be evaluated by the European Medicine Agency, and will only be authorised and placed on the market if they are safe and effective, according to von der Leyen.

“Transparency is crucial and of the utmost importance,” she said. “Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on a pro-rata basis, at the same conditions.”

Related News:

 

The contract with Moderna will be the sixth contract for a Covid-19 vaccine that the EU approves, and the Commission is working on a seventh one as well.


“The EU is working on one of the most comprehensive vaccine portfolios in the world,” von der Leyen said. “This provides Europeans access to the most promising future vaccines under development so far.”

Maïthé Chini
The Brussels Times